Proteome Sciences' research capability has been significantly expanded through collaboration agreements with leading academics and academic research institutions across the world and through grant funding. This provides Proteome Sciences with access to world leading establishments and teams specialising in the application of proteomic technologies to human disease and access to highly characterised disease samples.

Proteome Sciences has entered into an exclusive licence agreement for it's TMT® reagents with Thermo Scientific. View Thermo Scientific's press release on the launch of TMT® reagents here.